TIMP-1 induces α-smooth muscle actin in fibroblasts to promote urethral scar formation

Cellular Physiology and Biochemistry

Volumn 35, Issue 6, 2015, Pages 2233-2243

  Sa, Yinglong ^a   Li, Chao ^a   Li, Hongbin ^a   Guo, Hailin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition (EMT); Tissue inhibitor of metalloproteinases 1 (TIMP 1); Transforming growth factor 1 (TGF 1); Urethral scar; smooth muscle actin ( SMA)

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; LENTIVIRUS VECTOR; MITOGEN ACTIVATED PROTEIN KINASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; ACTA2 PROTEIN, HUMAN; ACTIN; TIMP1 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL INVASION; CELL ISOLATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOFIBROBLAST; PRIORITY JOURNAL; SCAR; SCAR FORMATION; SIGNAL TRANSDUCTION; TRANSGENE; URETHRA DISEASE; URETHRAL SCAR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; URETHRA;

ACTINS; CICATRIX; COLLAGEN TYPE I; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MYOFIBROBLASTS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA1; URETHRA;

EID: 84928152206     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374028     Document Type: Article

References (51)

1. Tritschler S, Roosen A, Fullhase C, Stief CG, Rubben H: Urethral stricture: Etiology, investigation and treatments. Dtsch Arztebl Int 2013;110:220-226.
2. Mangera A, Chapple C: Management of anterior urethral stricture: An evidence-based approach. Curr Opin Urol 2010;20:453-458.
3. Elliott SP, McAninch JW: The current role of urethrotomy in anterior urethral stricture disease. Curr Urol Rep 2006;7:339-340.
4. Naude AM, Heyns CF: What is the place of internal urethrotomy in the treatment of urethral stricture disease? Nat Clin Prac Urol 2005;2:538-545.
5. Li C, Xu YM, Li HB: Preliminary experimental study of urethral reconstruction with tissue engineering and rna interference techniques. Asian J Androl 2013;15:430-433.
6. Palminteri E, Berdondini E, Maruccia S, Larocca L, Iannotta L, Franco G, Gentile V, Ceccarelli S, Marchese C: [preliminary resultson the use of autologous cell culture grafts of buccal mucosa in urethral repairs]. Urologia 2012;79:S111-115.
7. Ayyildiz A, Nuhoglu B, Gulerkaya B, Caydere M, Ustun H, Germiyanoglu C, Erol D: Effect of intraurethral mitomycin-c on healing and fibrosis in rats with experimentally induced urethral stricture. Int J Urol 2004;11:1122-1126.
8. Baskin LS, Constantinescu SC, Howard PS, McAninch JW, Ewalt DH, Duckett JW, Snyder HM, Macarak EJ: Biochemical characterization and quantitation of the collagenous components of urethral stricture tissue. J Urol 1993;150:642-647.
9. Liu G, Jiang C, Li D, Wang R, Wang W: Mirna-34a inhibits egfr-signaling-dependent mmp7 activation in gastric cancer. Tumour Biol 2014;35:9801-9806.
10. Wang X, Cao X: Regulation of metastasis of pediatric multiple myeloma by mmp13. Tumour Biol 2014;35:8715-8720.
11. Zhou X, Qi Y: Plgf inhibition impairs metastasis of larynx carcinoma through mmp3 downregulation. Tumour Biol 2014;35:9381-9386.
12. Wang F, Xiao W, Sun J, Han D, Zhu Y: Mirna-181c inhibits egfr-signaling-dependent mmp9 activation via suppressing akt phosphorylation in glioblastoma. Tumour Biol 2014;35:8653-8658.
13. Ding H, Zhu Y, Chu T, Wang S: Epidermal growth factor induces foxo1 nuclear exclusion to activate mmp7-mediated metastasis of larynx carcinoma. Tumour Biol 2014;35:9987-9992.
14. Ries C: Cytokine functions of timp-1. Cell Mol Life Sci 2014;71:659-672.
15. Bodden MK, Windsor LJ, Caterina NC, Yermovsky A, Birkedal-Hansen B, Galazka G, Engler JA, Birkedal-Hansen H: Analysis of the timp-1/fib-cl complex. Ann N Y Acad Sci 1994;732:84-95.
16. Arthur MJ, Iredale JP: Hepatic lipocytes, timp-1 and liver fibrosis. J R Coll Physicians Lond 1994;28:200-208.
17. Huang X, Wei DP, Yang YR: [detection of collagenase activity and tissue inhibitor of metalloproteinase-1 expression level in the urethral scar tissue]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2003;17:433-435.
18. Chen B, Wen Y, Zhang Z, Wang H, Warrington JA, Polan ML: Menstrual phase-dependent gene expression differences in periurethral vaginal tissue from women with stress incontinence. Am J Obstet Gynecol 2003;189:89-97.
19. Chen B, Wen Y, Wang H, Polan ML: Differences in estrogen modulation of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-1 expression in cultured fibroblasts from continent and incontinent women. Am J Obstet Gynecol 2003;189:59-65.
20. Gobet R, Bleakley J, Cisek L, Kaefer M, Moses MA, Fernandez CA, Peters CA: Fetal partial urethral obstruction causes renal fibrosis and is associated with proteolytic imbalance. J Urol 1999;162:854-860.
21. Egea V, Zahler S, Rieth N, Neth P, Popp T, Kehe K, Jochum M, Ries C: Tissue inhibitor of metalloproteinase-1 (timp-1) regulates mesenchymal stem cells through let-7f microrna and wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 2012;109:E309-316.
22. Liang CC, Park AY, Guan JL: In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007;2:329-333.
23. Jung YS, Liu XW, Chirco R, Warner RB, Fridman R, Kim HR: Timp-1 induces an emt-like phenotypic conversion in mdck cells independent of its mmp-inhibitory domain. PLoS One 2012;7:e38773.
24. Shen B, Liu X, Fan Y, Qiu J: Macrophages regulate renal fibrosis through modulating tgfbeta superfamily signaling. Inflammation 2014;37:2076-2084.
25. Wu TH, Li CH, Tang MJ, Liang JI, Chen CH, Yeh ML: Migration speed and directionality switch of normal epithelial cells after tgf-beta1-induced emt (temt) on micro-structured polydimethylsiloxane (pdms) substrates with variations in stiffness and topographic patterning. Cell Commun Adhes 2013;20:115-126.
26. Doerner AM, Zuraw BL: Tgf-beta1 induced epithelial to mesenchymal transition (emt) in human bronchial epithelial cells is enhanced by il-1beta but not abrogated by corticosteroids. Respir Res 2009;10:100.
27. Aresu L, Rastaldi MP, Scanziani E, Baily J, Radaelli E, Pregel P, Valenza F: Epithelial-mesenchymal transition (emt) of renal tubular cells in canine glomerulonephritis. Virchows Arch 2007;451:937-942.
28. Shang Y, Cai X, Fan D: Roles of epithelial-mesenchymal transition in cancer drug resistance. Curr Cancer Drug Targets 2013;13:915-929.
29. Kiesslich T, Pichler M, Neureiter D: Epigenetic control of epithelial-mesenchymal-transition in human cancer. Mol Clin Oncol 2013;1:3-11.
30. Meng F, Wu G: The rejuvenated scenario of epithelial-mesenchymal transition (emt) and cancer metastasis. Cancer Metastasis Rev 2012;31:455-467.
31. Leroy P, Mostov KE: Slug is required for cell survival during partial epithelial-mesenchymal transition of hgf-induced tubulogenesis. Mol Biol Cell 2007;18:1943-1952.
32. Lamorte L, Royal I, Naujokas M, Park M: Crk adapter proteins promote an epithelial-mesenchymallike transition and are required for hgf-mediated cell spreading and breakdown of epithelial adherens junctions. Mol Biol Cell 2002;13:1449-1461.
33. Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, Song Z, El-Gohary Y, Prasadan K, Shiota C, Gittes GK: M2 macrophages promote beta-cell proliferation by up-regulation of smad7. Proc Natl Acad Sci U S A 2014;111:E1211-1220.
34. Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, Morris M, Wyatt L, Farshid G, Lim YY, Lindeman GJ, Shannon MF, Drew PA, Khew-Goodall Y, Goodall GJ: An autocrine tgf-beta/zeb/mir-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell 2011;22:1686-1698.
35. Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A: Tgf-beta and the smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 2005;16:1987-2002.
36. Muthusami S, Prabakaran DS, Yu JR, Park WY: Egf-induced expression of fused toes homolog (fts) facilitates epithelial-mesenchymal transition and promotes cell migration in me180 cervical cancer cells. Cancer Lett 2014;351:252-259.
37. Sakuma K, Aoki M, Kannagi R: Transcription factors c-myc and cdx2 mediate e-selectin ligand expression in colon cancer cells undergoing egf/bfgf-induced epithelial-mesenchymal transition. Proc Natl Acad Sci U S A 2012;109:7776-7781.
38. Shirakihara T, Horiguchi K, Miyazawa K, Ehata S, Shibata T, Morita I, Miyazono K, Saitoh M: Tgf-beta regulates isoform switching of fgf receptors and epithelial-mesenchymal transition. EMBO J 2011;30:783-795.
39. Ramos C, Becerril C, Montano M, Garcia-De-Alba C, Ramirez R, Checa M, Pardo A, Selman M: Fgf-1 reverts epithelial-mesenchymal transition induced by tgf-{beta}1 through mapk/erk kinase pathway. Am J Physiol Lung Cell Mol Physiol 2010;299:L222-231.
40. Billottet C, Tuefferd M, Gentien D, Rapinat A, Thiery JP, Broet P, Jouanneau J: Modulation of several waves of gene expression during fgf-1 induced epithelial-mesenchymal transition of carcinoma cells. J Cell Biochem 2008;104:826-839.
41. Yang N, Hui L, Wang Y, Yang H, Jiang X: Overexpression of sox2 promotes migration, invasion, and epithelial-mesenchymal transition through the wnt/beta-catenin pathway in laryngeal cancer hep-2 cells. Tumour Biol 2014;35:7965-7973.
42. Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W, Hou F, Ge J, Zhong M, Tang Y, Xia X, Chen Z: Epha2 promotes epithelial-mesenchymal transition through the wnt/beta-catenin pathway in gastric cancer cells. Oncogene 2014;33:2737-2747.
43. Kang M, Choi S, Jeong SJ, Lee SA, Kwak TK, Kim H, Jung O, Lee MS, Ko Y, Ryu J, Choi YJ, Jeong D, Lee HJ, Ye SK, Kim SH, Lee JW: Cross-talk between tgfbeta1 and egfr signalling pathways induces tm4sf5 expression and epithelial-mesenchymal transition. Biochem J 2012;443:691-700.
44. Massague J: Tgfbeta signalling in context. Nat Rev Mol Cell Biol 2012;13:616-630.
45. Chen T, Nie H, Gao X, Yang J, Pu J, Chen Z, Cui X, Wang Y, Wang H, Jia G: Epithelial-mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via tgf-beta/smad signaling pathway. Toxicol Lett 2014;226:150-162.
46. Sassoli C, Chellini F, Pini A, Tani A, Nistri S, Nosi D, Zecchi-Orlandini S, Bani D, Formigli L: Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of tgf-beta/smad3 signaling. PLoS One 2013;8:e63896.
47. Gui T, Sun Y, Shimokado A, Muragaki Y: The roles of mitogen-activated protein kinase pathways in tgf-betainduced epithelial-mesenchymal transition. J Signal Transduct 2012;2012:289243.
48. Yoshimatsu Y, Watabe T: Roles of tgf-beta signals in endothelial-mesenchymal transition during cardiac fibrosis. Int J Inflamm 2011;2011:724080.
49. Schneider DJ, Wu M, Le TT, Cho SH, Brenner MB, Blackburn MR, Agarwal SK: Cadherin-11 contributes to pulmonary fibrosis: Potential role in tgf-beta production and epithelial to mesenchymal transition. FASEB J 2012;26:503-512.
50. Hills CE, Squires PE: The role of tgf-beta and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev 2011;22:131-139.
51. Masszi A, Fan L, Rosivall L, McCulloch CA, Rotstein OD, Mucsi I, Kapus A: Integrity of cell-cell contacts is a critical regulator of tgf-beta 1-induced epithelial-to-myofibroblast transition: Role for beta-catenin. Am J Pathol 2004;165:1955-1967.